2Spatially distinct cellular and molecular landscapes define prognosis in triple-negative breast cancer.2026 · PubMed
3Estimating total and diagnosed global cancer incidence and stage distribution from 1990 to 2050: a simulation-based analysis of 17 cancers.2026 · PubMed
4Tumor microenvironment-driven drug resistance in urologic cancers: mechanisms and therapeutic targets.2026 · PubMed
5Rationale and recommendations for improving early-stage oncology diagnosis, treatment, and access.2026 · PubMed
6[CHALLENGE accepted! Exercise in oncology: from "Supportive Care" to "Effective Treatment"].2026 · PubMed
8Cancer incidence and mortality among older adults in Asia: Estimates for 2022 and projections to 2050.2026 · PubMed
10Combined FAK and MEK inhibition suppresses chromosome 8 gain malignant peripheral nerve sheath tumors.2026 · PubMed
11Loss of Kmt2c/d promotes gastric cancer and confers vulnerability to mTORC1 and PD-1 inhibition.2026 · PubMed
12Harnessing the gut microbiota in extra-intestinal cancers: from causal evidence to immunotherapy strategies.2026 · PubMed
13TIPE3 in Cancer: A Multifaceted Regulator of Tumorigenesis, Therapeutic Resistance, and Clinical Outcomes.2026 · PubMed
17Advancing precision chemotherapy and overcoming resistance mechanisms through sortilin-directed peptide-drug conjugates.2026 · PubMed
19Neoplasm risk in individuals with neurofibromatosis 1 - a Danish nationwide cohort study with long-term follow-up.2026 · PubMed
20FOXM1 induces therapy resistance and inhibits apoptosis in a variety of human cancers.2026 · PubMed
22Awareness of the link between HPV and cancer according to cancer type and gender in the US from 2014-2020.2026 · PubMed
23Tescalcin is a phagocytic checkpoint driving immune escape and limiting immunotherapeutic efficacy in hepatocellular carcinoma.2026 · PubMed
25Longitudinal Analysis of Oral Potentially Malignant Disorder Conversion to Malignancy.2026 · PubMed
28Overcoming toxicity challenges in immune checkpoint inhibitor treatment of high-risk metastatic cancers.2026 · PubMed
29Ferroptosis and chemotherapy resistance in ovarian cancer: molecular mechanisms and therapeutic opportunities.2026 · PubMed
30Immunoscore and beyond: evolution and clinical integration of immune contexture-based biomarkers across solid tumours.2026 · PubMed
32Relative survival of large cell to small cell neuroendocrine carcinoma of the uterine cervix.2026 · PubMed
36Enhancer and metabolic rewiring by KMT2C-COMPASS or KMT2D-COMPASS family loss in cancer creates druggable vulnerabilities.2026 · PubMed
38Metabolomic and transcriptomic analyses identify metabolic alterations and immune suppression in ovarian cancer.2026 · PubMed
42Integrating multi-omics and artificial intelligence for personalized breast cancer management: A guide to clinicians.2026 · PubMed
43Neoantigen-driven cancer vaccines in personalized oncology: progress, obstacles, and translational prospects.2026 · PubMed
44Cancer-Derived Exosomes: A Cross-Cancer Comparative Analysis of Exosomal Proteins and MicroRNAs.2026 · PubMed
45Recent Advances in Pancreatic Cancer and Biliary Tract Cancers: Biology, Biomarkers, and Evolving Systemic Therapy.2026 · PubMed
46Reversing enhancer RNA-mediated IKBKE gene repression enables synthetic anticancer immunity in prostate cancer models.2026 · PubMed
47PARylation-centric crosstalk: orchestrating immune evasion and multidrug resistance in ovarian cancer.2026 · PubMed
59Integrating antibody-drug conjugates into solid tumor oncology: Current standards and future directions.2026 · PubMed